Traing Source
ABUS Split History ยป
Video: Compound Annual Growth Rate (CAGR) Definition

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Latest Articles

sun life financial dividend history how much is pepsi stock time warner cable stock split colorado interstate gas company llc stock price of bank of new york mellon illinois tool works stock price stillwater mining stock price today jp morgan chase stock price what is ge stock worth today reinsurance group of america stock price ford motor company stock price today manulife financial stock price today stock quote las vegas sands energy transfer partners stock price stock symbol for hewlett packard procter & gamble stock price today marsh and mclennan stock price abercrombie and fitch stock quote norfolk southern railroad stock price precision castparts corp stock price capital federal savings and loan novo nordisk stock price today southern california edison stock price johnson and johnson stock price and dividend st jude medical stock quote stock symbol for exxon mobil alps alerian mlp etf dividend www newbridgebank com online banking stock price coca cola today duke energy stock dividend history m and t bank stock
Date Open High Low Close Volume
01/12/2018 $5.05 $5.15 $5.00 $5.10 56.30K
01/16/2018 $5.05 $5.53 $4.90 $5.05 281.70K
01/17/2018 $5.10 $5.25 $5.00 $5.20 125.50K
01/18/2018 $5.15 $5.30 $5.05 $5.20 135.50K
01/19/2018 $5.20 $5.25 $5.05 $5.20 99.80K
Arbutus Biopharma is a therapeutic solutions company focused on discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus (HBV) infection. Co.'s HBV pipeline consists of multiple drug candidates, with differing and complementary mechanisms of action. The candidates include: RNAi 1.0 (ARB-1467), which is Co.'s main RNA Interference (RNAi) HBV candidate designed to eliminate HBV surface antigen expression in patients chronically infected with HBV; RNAi 2.0 (ARB-1740), Co.'s follow-on RNAi HBV candidate; and Core Protein/ Capsid Assembly Inhibitors (AB-423), which is being developed as oral therapeutics for the treatment of chronic HBV infection.
ABUS historical stock prices picture
Arbutus Biopharma (ABUS) has the following price history information. Looking back at ABUS historical stock prices for the last five trading days, on January 12, 2018, ABUS opened at $5.05, traded as high as $5.15 and as low as $5.00, and closed at $5.10. Trading volume was a total of 56.30K shares. On January 16, 2018, ABUS opened at $5.05, traded as high as $5.53 and as low as $4.90, and closed at $5.05. Trading volume was a total of 281.70K shares. On January 17, 2018, ABUS opened at $5.10, traded as high as $5.25 and as low as $5.00, and closed at $5.20. Trading volume was a total of 125.50K shares. On January 18, 2018, ABUS opened at $5.15, traded as high as $5.30 and as low as $5.05, and closed at $5.20. Trading volume was a total of 135.50K shares. On January 19, 2018, ABUS opened at $5.20, traded as high as $5.25 and as low as $5.05, and closed at $5.20. Trading volume was a total of 99.80K shares.

ABUS Historical Stock Prices By Date:

ABUS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $5.00
End price/share: $5.20
Dividends collected/share: $0.00
Total return: 4.00%
Average Annual Total Return: 0.39%
Starting investment: $10,000.00
Ending investment: $10,396.92
Years: 10.00
Date Close
ABUS is categorized under the Healthcare sector; below are some other companies in the same sector:

ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACIU Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices

ABUS Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .